Articoli di riviste sul tema "Philip Johnson Associates"
Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili
Vedi i top-43 articoli di riviste per l'attività di ricerca sul tema "Philip Johnson Associates".
Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.
Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.
Vedi gli articoli di riviste di molte aree scientifiche e compila una bibliografia corretta.
Chohan, S., A. Kavanaugh, V. Strand, R. C. Chou, A. M. Mendelsohn, S. Rozzo e P. J. Mease. "AB0803 EFFICACY OF TILDRAKIZUMAB IN PsA: DAS28-CRP SCORES THROUGH WEEK 52". Annals of the Rheumatic Diseases 79, Suppl 1 (giugno 2020): 1702–3. http://dx.doi.org/10.1136/annrheumdis-2020-eular.3907.
Testo completoJayne, D., P. Gavin, E. Allman, C. Di Poto, X. Tian, S. Hess, M. Ramaswamy et al. "OP0136 METABOLOMIC SERUM PROFILING IDENTIFIES METABOLITES LINKED TO KIDNEY DAMAGE WHICH ARE MODULATED BY ANIFROLUMAB IN A PHASE 2 TRIAL IN LUPUS NEPHRITIS". Annals of the Rheumatic Diseases 82, Suppl 1 (30 maggio 2023): 90.1–90. http://dx.doi.org/10.1136/annrheumdis-2023-eular.1569.
Testo completoPray, C., N. Narula, E. C. Wong, J. K. Marshall, S. Rangarajan, S. Islam, A. Bahonar et al. "A176 ASSOCIATIONS OF ANTIBIOTICS, HORMONAL THERAPIES, ORAL CONTRACEPTIVES, AND LONG-TERM NSAIDS WITH INFLAMMATORY BOWEL DISEASE: RESULTS FROM THE PROSPECTIVE URBAN RURAL EPIDEMIOLOGY (PURE) STUDY". Journal of the Canadian Association of Gastroenterology 6, Supplement_1 (1 marzo 2023): 20–22. http://dx.doi.org/10.1093/jcag/gwac036.176.
Testo completoRahman, P., C. T. Ritchlin, P. Helliwell, W. H. Boehncke, P. J. Mease, A. B. Gottlieb, S. Kafka et al. "FRI0359 INTEGRATED SAFETY RESULTS OF TWO PHASE-3 TRIALS OF GUSELKUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS THROUGH THE PLACEBO-CONTROLLED PERIODS". Annals of the Rheumatic Diseases 79, Suppl 1 (giugno 2020): 776–77. http://dx.doi.org/10.1136/annrheumdis-2020-eular.387.
Testo completoRahman, P., P. J. Mease, A. Deodhar, A. Kavanaugh, S. D. Chakravarty, A. Kollmeier, Y. Liu, M. Shawi e C. Han. "OP0025 FACTORS ASSOCIATED WITH FATIGUE AND ITS IMPROVEMENT – A PRINCIPAL COMPONENT ANALYSIS OF PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS FROM GUSELKUMAB PHASE 3 TRIALS". Annals of the Rheumatic Diseases 81, Suppl 1 (23 maggio 2022): 18–19. http://dx.doi.org/10.1136/annrheumdis-2022-eular.895.
Testo completoCoates, L. C., C. T. Ritchlin, L. Gossec, P. Helliwell, P. Rahman, E. C. Hsia, A. Kollmeier et al. "POS1024 GUSELKUMAB PROVIDES SUSTAINED DOMAIN-SPECIFIC AND COMPREHENSIVE EFFICACY AS ASSESSED USING COMPOSITE ENDPOINTS IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS". Annals of the Rheumatic Diseases 80, Suppl 1 (19 maggio 2021): 781–82. http://dx.doi.org/10.1136/annrheumdis-2021-eular.167.
Testo completoCurtis, J., I. Mcinnes, D. D. Gladman, F. Yang, S. Peterson, P. Agarwal, A. Kollmeier et al. "POS1028 PATIENT CHARACTERISTICS & CLINICAL FEATURES ASSOCIATE WITH HEALTH-RELATED QUALITY OF LIFE IN BIO-NAÏVE PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS THROUGH WEEK 24 OF THE DISCOVER-2 STUDY". Annals of the Rheumatic Diseases 80, Suppl 1 (19 maggio 2021): 784–85. http://dx.doi.org/10.1136/annrheumdis-2021-eular.432.
Testo completoCoates, L., J. Ramírez, D. Mcgonagle, S. Aydin, M. Zimmermann, F. Nantel, M. Shawi, E. Rampakakis, P. Nash e P. J. Mease. "POS1540 EARLY SKIN AND EARLY ENTHESITIS RESPONSES IN PSORIATIC ARTHRITIS PATIENTS TREATED WITH GUSELKUMAB ASSOCIATE WITH LONG-TERM RESPONSE: POST HOC ANALYSIS THROUGH 2 YEARS OF A PHASE 3 STUDY". Annals of the Rheumatic Diseases 82, Suppl 1 (30 maggio 2023): 1137.1–1137. http://dx.doi.org/10.1136/annrheumdis-2023-eular.2581.
Testo completoMcgonagle, D., I. Mcinnes, A. Deodhar, G. Schett, P. J. Mease, M. Shawi, S. Kafka et al. "AB0801 EFFECTS OF GUSELKUMAB, A MONOCLONAL ANTIBODY THAT SPECIFICALLY BINDS TO THE P19-SUBUNIT OF INTERLEUKIN-23, ON DACTYLITIS AND ENTHESITIS IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: POOLED RESULTS THROUGH WEEK 24 FROM TWO PHASE 3 STUDIES". Annals of the Rheumatic Diseases 79, Suppl 1 (giugno 2020): 1701.2–1701. http://dx.doi.org/10.1136/annrheumdis-2020-eular.836.
Testo completoCurtis, J., I. McInnes, P. Rahman, D. D. Gladman, F. Yang, S. Peterson, A. Kollmeier et al. "AB0881 Guselkumab Provides Sustained Improvements in Health-Related Quality of Life in Patients With Active Psoriatic Arthritis Through 2 Years of DISCOVER-2". Annals of the Rheumatic Diseases 81, Suppl 1 (23 maggio 2022): 1563.2–1564. http://dx.doi.org/10.1136/annrheumdis-2022-eular.733.
Testo completoGossec, L., D. Aletaha, P. Sewerin, A. Zabotti, F. Van den Bosch, M. Efficace, F. Lavie, M. Zimmermann, M. Sharaf e I. Mcinnes. "AB1082 EARLY CLINICAL RESPONSE AS A PREDICTOR OF LONG-TERM HEALTH-RELATED QUALITY OF LIFE IMPROVEMENTS IN PATIENTS WITH PSORIATIC ARTHRITIS AND TNFI-IR RECEIVING GUSELKUMAB (COSMOS)". Annals of the Rheumatic Diseases 82, Suppl 1 (30 maggio 2023): 1761.1–1761. http://dx.doi.org/10.1136/annrheumdis-2023-eular.359.
Testo completoSewerin, P., L. Dötsch, D. Truhm, D. Abrar e S. Nebelung. "THU0062 FUNCTIONAL MR IMAGING OF HUMAN MENISCUS IS ASSOCIATED WITH HISTOLOGICAL DEGENERATION". Annals of the Rheumatic Diseases 79, Suppl 1 (giugno 2020): 243. http://dx.doi.org/10.1136/annrheumdis-2020-eular.6403.
Testo completoCoates, L., I. Mcinnes, S. Aydin, M. Kishimoto, P. J. Mease, M. Shawi, M. Zimmermann, E. Rampakakis, F. Lavie e D. Mcgonagle. "POS0027 INDIVIDUAL ENTHESEAL POINTS HAVE DIFFERENTIAL FREQUENCY OF INVOLVEMENT AND IMPACT ON PATIENT REPORTED OUTCOMES IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: POOLED ANALYSIS OF TWO PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDIES". Annals of the Rheumatic Diseases 82, Suppl 1 (30 maggio 2023): 220–21. http://dx.doi.org/10.1136/annrheumdis-2023-eular.122.
Testo completoCurtis, J., I. Mcinnes, S. Peterson, P. Agarwal, F. Yang, A. Kollmeier, E. C. Hsia et al. "POS1026 GUSELKUMAB PROVIDES SUSTAINED IMPROVEMENTS IN WORK PRODUCTIVITY AND NON-WORK ACTIVITY IN PATIENTS WITH PSORIATIC ARTHRITIS: RESULTS THROUGH 1 YEAR OF A PHASE 3 TRIAL". Annals of the Rheumatic Diseases 80, Suppl 1 (19 maggio 2021): 782.2–783. http://dx.doi.org/10.1136/annrheumdis-2021-eular.244.
Testo completoNash, P., I. Mcinnes, C. T. Ritchlin, L. S. Tam, E. Soriano, M. Starr, E. Rampakakis et al. "AB1095 IMPACT OF PSORIATIC ARTHRITIS MANIFESTATIONS ON PERCEPTION OF PAIN IMPROVEMENT: POOLED ANALYSIS OF TWO PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDIES WITH GUSELKUMAB". Annals of the Rheumatic Diseases 82, Suppl 1 (30 maggio 2023): 1771–72. http://dx.doi.org/10.1136/annrheumdis-2023-eular.555.
Testo completoBaraliakos, X., D. D. Gladman, S. D. Chakravarty, C. Gong, M. Shawi, E. Rampakakis, M. Kishimoto, E. Soriano e P. J. Mease. "POS0023 PERFORMANCE OF BASDAI VS. ASDAS IN EVALUATING AXIAL INVOLVEMENT IN PATIENTS WITH PSA TREATED WITH GUSELKUMAB: POOLED ANALYSIS OF TWO PHASE 3 STUDIES". Annals of the Rheumatic Diseases 82, Suppl 1 (30 maggio 2023): 217.2–218. http://dx.doi.org/10.1136/annrheumdis-2023-eular.2761.
Testo completoGladman, D. D., M. Starr, R. Ranza, A. M. Bravo Perdomo, M. Strauss, M. Shawi, C. Han, E. Rampakakis, A. Andrew Östör e P. J. Mease. "AB1087 LONG-TERM EFFICACY OF GUSELKUMAB IN FATIGUE AND IDENTIFICATION OF EARLY TREATMENT TARGETS: POST HOC ANALYSIS THROUGH 2 YEARS OF A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY CONDUCTED IN BIOLOGIC-NAÏVE PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS". Annals of the Rheumatic Diseases 82, Suppl 1 (30 maggio 2023): 1765.1–1765. http://dx.doi.org/10.1136/annrheumdis-2023-eular.1918.
Testo completoMease, P. J., P. Foley, K. Reich, J. Bagel, M. Lebwohl, Y. W. Yang, M. Shawi et al. "POS1031 LOW INCIDENCE OF GASTROINTESTINAL-RELATED AND OVERALL SERIOUS ADVERSE EVENTS AMONG GUSELKUMAB-TREATED PATIENTS: POOLED ANALYSES OF VOYAGE 1 & 2 AND DISCOVER 1 & 2 THROUGH 1-YEAR". Annals of the Rheumatic Diseases 80, Suppl 1 (19 maggio 2021): 787–88. http://dx.doi.org/10.1136/annrheumdis-2021-eular.558.
Testo completoOrbai, A. M., L. C. Coates, A. Deodhar, P. Helliwell, C. T. Ritchlin, A. Kollmeier, E. C. Hsia et al. "POS1029 GUSELKUMAB-TREATED PATIENTS WITH PSORIATIC ARTHRITIS ACHIEVED CLINICALLY MEANINGFUL IMPROVEMENTS IN GENERAL HEALTH OUTCOMES MEASURED WITH PROMIS-29 THROUGH 52 WEEKS: RESULTS FROM THE PHASE 3 DISCOVER-1 TRIAL". Annals of the Rheumatic Diseases 80, Suppl 1 (19 maggio 2021): 785–86. http://dx.doi.org/10.1136/annrheumdis-2021-eular.471.
Testo completoCurtis, J., I. Mcinnes, P. Rahman, D. D. Gladman, F. Yang, S. Peterson, A. Kollmeier et al. "AB0888 Guselkumab Provides Sustained Improvements in Work Productivity and Daily Activity in Patients With Active Psoriatic Arthritis Through 2 Years of DISCOVER-2". Annals of the Rheumatic Diseases 81, Suppl 1 (23 maggio 2022): 1568–69. http://dx.doi.org/10.1136/annrheumdis-2022-eular.1366.
Testo completoCoates, L., P. Rahman, P. J. Mease, M. Shawi, E. Rampakakis, A. Kollmeier, X. L. Xu, S. D. Chakravarty, I. Mcinnes e L. S. Tam. "POS1067 DOMAINS CONTRIBUTING TO MINIMAL DISEASE ACTIVITY ACHIEVEMENT IN PATIENTS WITH PSORIATIC ARTHRITIS RECEIVING GUSELKUMAB". Annals of the Rheumatic Diseases 81, Suppl 1 (23 maggio 2022): 856–57. http://dx.doi.org/10.1136/annrheumdis-2022-eular.893.
Testo completoRitchlin, C. T., P. J. Mease, W. H. Boehncke, J. Tesser, S. D. Chakravarty, E. Rampakakis, M. Shawi et al. "AB1104 STRINGENT DISEASE ACTIVITY CONTROL AT 2 YEARS ACROSS PSORIATIC ARTHRITIS DOMAINS IRRESPECTIVE OF BASELINE CHARACTERISTICS IN PATIENTS TREATED WITH GUSELKUMAB: POST-HOC ANALYSIS OF A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY". Annals of the Rheumatic Diseases 82, Suppl 1 (30 maggio 2023): 1779–80. http://dx.doi.org/10.1136/annrheumdis-2023-eular.3238.
Testo completoTillett, W., L. Coates, M. Vis, E. Soriano, J. F. Merola, M. Zimmermann, M. Shawi, M. Sharaf, P. Nash e P. Helliwell. "POS1535 EARLY IMPROVEMENT IN 3VAS/4VAS PREDICTS REDUCED RATES OF RADIOGRAPHIC CHANGE IN BIO-NAIVE ACTIVE PSORIATIC ARTHRITIS PATIENTS RECEIVING GUSELKUMAB TREATMENT". Annals of the Rheumatic Diseases 82, Suppl 1 (30 maggio 2023): 1131–32. http://dx.doi.org/10.1136/annrheumdis-2023-eular.1690.
Testo completoDu, Wenxuan, Adrian Johnston, Praful Nair, Jingyi Zhu, Khin Sandar Win, Bryan Zhou, Jude Phillip, Pei-Hsun Wu e Denis Wirtz. "Abstract 5949: Modulate TAM infiltration at cancer-immune interface by targeting at monocyte migration". Cancer Research 83, n. 7_Supplement (4 aprile 2023): 5949. http://dx.doi.org/10.1158/1538-7445.am2023-5949.
Testo completoLippert, Anna L., Katherine A. Johnson, Cheri A. Pasch, Sean G. Kraus, Philip B. Emmerich, Linda Clipson, Kristina A. Matkowskyj, Wei Zhang e Dustin A. Deming. "Abstract 3198: Validation and analysis of cancer associated fibroblast subtype markers in metastatic colorectal cancer". Cancer Research 82, n. 12_Supplement (15 giugno 2022): 3198. http://dx.doi.org/10.1158/1538-7445.am2022-3198.
Testo completoGudikote, Jayanthi, Tina Cascone, Alissa Poteete, Piyada Sitthideatphaiboon, Sonia Patel, Yan Yang, Fahao Zhang et al. "Abstract 5733: Targeting nonsense-mediated decay restores p53 function in HPV-associated head and neck cancers". Cancer Research 82, n. 12_Supplement (15 giugno 2022): 5733. http://dx.doi.org/10.1158/1538-7445.am2022-5733.
Testo completoTaylor, P. C., K. De Vlam, A. G. Bushmakin, L. Fallon, J. F. Merola, J. C. Cappelleri, M. A. Hsu e P. J. Mease. "AB0838 IDENTIFYING MEDIATORS OF PAIN REDUCTION IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH TOFACITINIB: ROLE OF INFLAMMATION ASSOCIATED WITH PERIPHERAL ARTHRITIS, ENTHESITIS AND SKIN DISEASE". Annals of the Rheumatic Diseases 79, Suppl 1 (giugno 2020): 1724–25. http://dx.doi.org/10.1136/annrheumdis-2020-eular.1052.
Testo completoJohnson, Katherine Anne, Anna L. Lippert, Sean G. Kraus, Grace E. McGrath, Philip B. Emmerich, Cheri A. Pasch, Linda Clipson, Kristina A. Matkowskyj, Wei Zhang e Dustin A. Deming. "Abstract 3533: Effects of tyrosine kinase inhibitors imatinib, dasatinib, and nilotinib on cancer-associated fibroblast phenotypes in colorectal cancer". Cancer Research 82, n. 12_Supplement (15 giugno 2022): 3533. http://dx.doi.org/10.1158/1538-7445.am2022-3533.
Testo completoDale, David, Audrey Anna Bolyard, Emily Dick, Merideth L. Kelley, Vahagn Makaryan, Ramsey Johnson, Lu Gan e Sudha Parasuraman. "X4P-001: A Novel Molecularly-Targeted Oral Therapy for Whim Syndrome". Blood 130, Suppl_1 (7 dicembre 2017): 995. http://dx.doi.org/10.1182/blood.v130.suppl_1.995.995.
Testo completoChaudhuri, Somak, Dustin A. Deming, Cheri A. Pasch, Katherine A. Johnson, Chelsie K. Sievers e Philip B. Emmerich. "Abstract 1581: Colony-stimulating factor-1 receptor as a potential therapeutic target in pancreatic ductal adenocarcinoma". Cancer Research 84, n. 6_Supplement (22 marzo 2024): 1581. http://dx.doi.org/10.1158/1538-7445.am2024-1581.
Testo completoBrooks, J., A. Montgomery, N. Dalbeth, M. Sapsford, A. Cooper, R. Ngan Kee, V. Quincey et al. "OP0079 OMICRON VARIANT INFECTION IN INFLAMMATORY RHEUMATOLOGICAL CONDITIONS - OUTCOMES FROM A COVID-19 NAIVE POPULATION IN AOTEAROA NEW ZEALAND". Annals of the Rheumatic Diseases 82, Suppl 1 (30 maggio 2023): 54–55. http://dx.doi.org/10.1136/annrheumdis-2023-eular.1749.
Testo completoHilliard, Tyvette, Phillip Petrasko, Yueying Liu, Jing Yang, Marwa Asem, Jeff Johnson, Gifty Marfowaa et al. "Abstract 2189: The role of generational obesity on the ovarian metastatic niche". Cancer Research 82, n. 12_Supplement (15 giugno 2022): 2189. http://dx.doi.org/10.1158/1538-7445.am2022-2189.
Testo completoGossec, L., P. J. Mease, A. B. Gottlieb, A. Ogdie, D. Assudani, J. Coarse, B. Ink e L. C. Coates. "AB0778 ASSOCIATION BETWEEN PATIENT-REPORTED OUTCOMES AND DISEASE ACTIVITY IN BIMEKIZUMAB-TREATED PATIENTS WITH PSORIATIC ARTHRITIS". Annals of the Rheumatic Diseases 79, Suppl 1 (giugno 2020): 1687.1–1687. http://dx.doi.org/10.1136/annrheumdis-2020-eular.4204.
Testo completoWahyuni, Anna Tri, Masfuri Masfuri e Liya Arista. "FAKTOR-FAKTOR YANG MEMPENGARUHI MORTALITAS PADA PASIEN DENGAN FRAKTUR COSTA: Literature Review". Jurnal Keperawatan Widya Gantari Indonesia 6, n. 2 (20 luglio 2022): 157. http://dx.doi.org/10.52020/jkwgi.v6i2.4151.
Testo completoMI KANG, YU, GIORGIO E. M. MELLONI, AVIVIT CAHN, ITAMAR RAZ, FILIPE MOURA, DEEPAK L. BHATT, SILVIO E. INZUCCHI et al. "1896-LB: Clinical Features and C-Peptide Levels Associated with Diabetic Ketoacidosis in Patients with Type 2 Diabetes on Dapagliflozin vs. Placebo—Insights from DECLARE-TIMI 58". Diabetes 73, Supplement_1 (14 giugno 2024). http://dx.doi.org/10.2337/db24-1896-lb.
Testo completoMI KANG, YU, GIORGIO E. M. MELLONI, AVIVIT CAHN, ITAMAR RAZ, FILIPE MOURA, DEEPAK L. BHATT, SILVIO E. INZUCCHI et al. "1895-LB: Fasting C-Peptide and Type 1 Diabetes Polygenic Score Predict Diabetic Ketoacidosis in People with Type 2 Diabetes in DECLARE-TIMI 58". Diabetes 73, Supplement_1 (14 giugno 2024). http://dx.doi.org/10.2337/db24-1895-lb.
Testo completoGao, Xiang. "A ‘Uniform’ for All States?" M/C Journal 26, n. 1 (15 marzo 2023). http://dx.doi.org/10.5204/mcj.2962.
Testo completoGoggin, Gerard, e Christopher Newell. "Fame and Disability". M/C Journal 7, n. 5 (1 novembre 2004). http://dx.doi.org/10.5204/mcj.2404.
Testo completoFelton, Emma. "Brisbane: Urban Construction, Suburban Dreaming". M/C Journal 14, n. 4 (22 agosto 2011). http://dx.doi.org/10.5204/mcj.376.
Testo completoHarrison, Karey. "Building Resilient Communities". M/C Journal 16, n. 5 (24 agosto 2013). http://dx.doi.org/10.5204/mcj.716.
Testo completoLyons, Craig, Alexandra Crosby e H. Morgan-Harris. "Going on a Field Trip: Critical Geographical Walking Tours and Tactical Media as Urban Praxis in Sydney, Australia". M/C Journal 21, n. 4 (15 ottobre 2018). http://dx.doi.org/10.5204/mcj.1446.
Testo completoRaffa, Taylor, Parker Chang, Babak Sarani e Susan Kartiko. "Surgical Stabilization of Rib Fractures: A Review of the Indications, Technique, and Outcomes". Medical Research Archives 11, n. 11 (2023). http://dx.doi.org/10.18103/mra.v11i11.4694.
Testo completoBrien, Donna Lee. "From Waste to Superbrand: The Uneasy Relationship between Vegemite and Its Origins". M/C Journal 13, n. 4 (18 agosto 2010). http://dx.doi.org/10.5204/mcj.245.
Testo completo